Use of fviia or fviiai for the treatment of adverse conditions related to the fviia mediated intracellular signalling pathway
A Standard patent application filed on 26 June 1998 credited to Kongsbak, Lars ; Bergenhem, Niels ; Foster, Don ; Thastrup, Ole ; Petersen, Lars Christian

Details

Application number :

81016  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of fviia or fviiai for the treatment of adverse conditions related to the fviia mediated intracellular signalling pathway  

Inventor :

Kongsbak, Lars ; Bergenhem, Niels ; Foster, Don ; Thastrup, Ole ; Petersen, Lars Christian  

Agent name :

 

Address for service :

 

Filing date :

26 June 1998  

Associated companies :

 

Applicant name :

Novo Nordisk A/S  

Applicant address :

 

Old name :

 

Original Source :

Go